These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36789314)

  • 21. [Severe hypocalcemia and hypomagnesemia in a 14-year-old boy--difficulties in treatment related to silent coeliac disease].
    Stacha W; Niedziela M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):191-4. PubMed ID: 16232374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tonic-clonic seizures in a patient with primary hypoparathyroidism: a case report.
    Armelisasso C; Vaccario ML; Pontecorvi A; Mazza S
    Clin EEG Neurosci; 2004 Apr; 35(2):97-9. PubMed ID: 15164818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism.
    Lupi I; Brancatella A; Cetani F; Latrofa F; Kemp EH; Marcocci C
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous Calcium-Sensing Receptor Polymorphism R544Q Presents as Hypocalcemic Hypoparathyroidism.
    Cavaco BM; Canaff L; Nolin-Lapalme A; Vieira M; Silva TN; Saramago A; Domingues R; Rutter MM; Hudon J; Gleason JL; Leite V; Hendy GN
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2879-2888. PubMed ID: 29846619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seizures as the first manifestation of chromosome 22q11.2 deletion syndrome in a 40-year old man: a case report.
    Tonelli AR; Kosuri K; Wei S; Chick D
    J Med Case Rep; 2007 Dec; 1():167. PubMed ID: 18053182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia.
    Nakajima K; Yamazaki K; Kimura H; Takano K; Miyoshi H; Sato K
    Intern Med; 2009; 48(22):1951-6. PubMed ID: 19915295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review.
    Song L; Liu L; Miller RT; Yan SX; Jackson N; Holt SA; Maalouf NM
    Eur J Endocrinol; 2017 Jul; 177(1):K1-K6. PubMed ID: 28515208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism.
    Ertl DA; Stary S; Streubel B; Raimann A; Haeusler G
    Bone; 2012 Sep; 51(3):629-32. PubMed ID: 22722080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
    Brown EM
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.
    Ji Y; Kang C; Chen J; Zhang L
    Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of hypokalemia in autosomal dominant hypocalcemia type 1.
    Kamiyoshi N; Nozu K; Urahama Y; Matsunoshita N; Yamamura T; Minamikawa S; Ninchoji T; Morisada N; Nakanishi K; Kaito H; Iijima K
    Clin Exp Nephrol; 2016 Apr; 20(2):253-7. PubMed ID: 26323216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.
    Suzuki M; Aso T; Sato T; Michimata M; Kazama I; Saiki H; Hatano R; Ejima Y; Miyama N; Sato A; Matsubara M
    Clin Nephrol; 2005 Jun; 63(6):481-6. PubMed ID: 15960151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms.
    Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB
    J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of seizure control due to anticonvulsant-induced hypocalcemia.
    Ali FE; Al-Bustan MA; Al-Busairi WA; Al-Mulla FA
    Ann Pharmacother; 2004 Jun; 38(6):1002-5. PubMed ID: 15084684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.